Japan Tobacco's Novel Osteoporosis Drug Promising in Early Study
MedPage Today -- DENVER -- Another calcium sensing receptor (CaSR) antagonist has shown promise as an osteoporosis treatment in an early clinical study, but skeptics wondered whether it will ultimately succeed where an earlier effort in this direction failed.